![Robert G. Boyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert G. Boyle
Grundare på
Sentinel Oncology Ltd.
Profil
Mr. Robert G.
Boyle is a Chief Executive Officer & Director at Sentinel Oncology Ltd. and an Advisor at o2h Ltd. He is on the Board of Directors at Sentinel Oncology Ltd. Mr. Boyle was previously employed as a Principal by Astex Technology Ltd., a Principal by Takeda Oncology Co., a Principal by Cambridge Discovery Chemistry, and a Principal by Pfizer Ltd.
Aktiva positioner av Robert G. Boyle
| Företag | Position | Start |
|---|---|---|
Sentinel Oncology Ltd.
 Sentinel Oncology Ltd. BiotechnologyHealth Technology Operates as a small molecule drug discovery company | Grundare | 2005-01-01 |
o2h Ltd
 o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Konsult / Rådgivare | - |
Tidigare kända positioner av Robert G. Boyle
| Företag | Position | Slut |
|---|---|---|
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Företagsledare/Principal | 2005-01-01 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Företagsledare/Principal | 2003-01-01 |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Provides chemistry research services | Företagsledare/Principal | 2000-01-01 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Företagsledare/Principal | 1997-01-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
78
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Cambridge Discovery Chemistry
Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Provides chemistry research services | Commercial Services |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops fragment based drug | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
Sentinel Oncology Ltd.
Sentinel Oncology Ltd. BiotechnologyHealth Technology Operates as a small molecule drug discovery company | Health Technology |
o2h Ltd
o2h Ltd Investment ManagersFinance O2h is an active manager which invests in EIS & SEIS companies located in the UK. The firm targets companies operating in the fields of pharmaceuticals, biotechnology, novel drug discovery, AI technologies, digital therapeutics and enabling services. It provides financing for seed and early stage capital requirements. | Finance |
